XYLOMETAZOLINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H24N2
Molecular Weight	244.3752
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of XYLOMETAZOLINE

Structure Search

SMILES

CC1=CC(=CC(C)=C1CC2=NCCN2)C(C)(C)C

InChI

InChIKey=HUCJFAOMUPXHDK-UHFFFAOYSA-N

InChI=1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18)

HIDE SMILES / InChI

Molecular Formula	C16H24N2
Molecular Weight	244.3752
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:32:20 UTC 2023` Edited by `admin` on `Fri Dec 15 15:32:20 UTC 2023`
Record UNII	WPY40FTH8K
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

XYLOMETAZOLINE

Official Name

English

1H-IMIDAZOLE, 2-((4-(1,1-DIMETHYLETHYL)-2,6-DIMETHYLPHENYL)METHYL)-4,5-DIHYDRO-

Systematic Name

English

xylometazoline [INN]

Common Name

English

Xylometazoline [WHO-DD]

Common Name

English

2-(4-TERT-BUTYL-2,6-DIMETHYLBENZYL)-2-IMIDAZOLINE

Systematic Name

English

XYLOMETAZOLINE [MI]

Common Name

English

XYLOMETAZOLINE [VANDF]

Common Name

English

BALMINIL

Brand Name

English

Classification Tree Code System Code

WHO-VATC

QS01GA03

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

NCI_THESAURUS

C29578

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-ESSENTIAL MEDICINES LIST

28

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-ATC

R01AB06

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-ATC

R01AA07

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-VATC

QR01AB06

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-ATC

S01GA53

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-VATC

QR01AA07

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-VATC

QS01GA53

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

WHO-ATC

S01GA03

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

NCI_THESAURUS

C29709

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

Code System Code Type Description

IUPHAR

517

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

MESH

C009695

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

DRUG BANK

DB06694

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

NCI_THESAURUS

C87749

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

SMS_ID

100000079363

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

RXCUI

39841

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

RxNorm

ECHA (EC/EINECS)

208-390-6

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

WIKIPEDIA

XYLOMETAZOLINE

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

MERCK INDEX

m11554

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

Merck Index

CAS

526-36-3

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

PUBCHEM

5709

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

EVMPD

SUB00122MIG

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

DAILYMED

WPY40FTH8K

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

EPA CompTox

DTXSID8046957

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

ChEMBL

CHEMBL312448

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

FDA UNII

WPY40FTH8K

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

INN

809

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

DRUG CENTRAL

3658

Created by admin on Fri Dec 15 15:32:20 UTC 2023 , Edited by admin on Fri Dec 15 15:32:20 UTC 2023

PRIMARY

Related Record Type Details


					3T7136LE8K

ALPHA-1A ADRENERGIC RECEPTOR

TARGET -> AGONIST


					X5S84033NZ

XYLOMETAZOLINE HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					93V99BB37L

ALPHA-2B ADRENERGIC RECEPTOR

TARGET -> AGONIST

Amount:


					50U1BO5G5P

ALPHA-2A ADRENERGIC RECEPTOR

TARGET -> AGONIST

Interaction Type:

SHORT-ACTING

Related Record Type Details


					C35A4W5KUD

N-(2-AMINOETHYL)-2-(4-(TERT-BUTYL)-2,6-DIMETHYLPHENYL)ACETAMIDE

IMPURITY -> PARENT

Related Record Type Details


					WPY40FTH8K

ACTIVE MOIETY